Vasoflex HD Disease Interactions
There are 4 disease interactions with Vasoflex HD (ascorbic acid).
Ascorbic acid (vitamin C) (applies to Vasoflex HD) hemolysis
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: G-6-PD Deficiency
Acute hemolysis following administration of high doses of ascorbic acid in patients with glucose-6-phosphate deficiency (G6PD) has been reported. Ascorbic acid should be administered cautiously and dosages modified in patients with G6PD.
Ascorbic acid (vitamin C) (applies to Vasoflex HD) kidney stones
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Nephrolithiasis
Large doses of ascorbic acid have lead to hyperoxaluria in 5% of patients. Ascorbic acid can acidify urine resulting in precipitation of urate, cystine, or oxalate stones. Ascorbic acid should be administered cautiously and dosages modified in patients predisposed to renal stones. Clinical monitoring of urinalysis for pH and crystal formation is recommended.
Ascorbic acid (vitamin C) (applies to Vasoflex HD) sodium
Moderate Potential Hazard, Low plausibility. Applicable conditions: Hypernatremia, Hypertension
Ascorbic acid preparations contain sodium. The sodium content should be considered when used in patients with sodium restricted diets and conditions require sodium restriction, such as congestive heart failure, hypertension, and fluid retention.
Ascorbic acid (vitamin C) (applies to Vasoflex HD) dialysis
Minor Potential Hazard, High plausibility. Applicable conditions: hemodialysis
Ascorbic acid is removed by dialysis.
Switch to professional interaction data
Vasoflex HD drug interactions
There are 31 drug interactions with Vasoflex HD (ascorbic acid).
Vasoflex HD alcohol/food interactions
There is 1 alcohol/food interaction with Vasoflex HD (ascorbic acid).
Report options
More about Vasoflex HD (ascorbic acid)
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Alpha E
Alpha E is used for alzheimer's disease, cystic fibrosis, dietary supplementation, nocturnal leg ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Aminoxin
Aminoxin is used for anemia, dietary supplementation, drug induced vitamin/mineral deficiency ...
Aqua Gem-E
Aqua Gem-E is used for alzheimer's disease, cystic fibrosis, dietary supplementation, nocturnal leg ...
Aquamephyton
Aquamephyton is used for hypoprothrombinemia, anticoagulant induced, hypoprothrombinemia, not ...
Aquasol E
Aquasol E is used for alzheimer's disease, cystic fibrosis, dietary supplementation, nocturnal leg ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.